×
About 10,237 results

ALLMedicine™ Myocarditis Center

Research & Reviews  5,059 results

Myocarditis in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Co...
https://doi.org/10.1097/CRD.0000000000000341
Cardiology in Review; Jain S, Nolan SM et. al.

Sep 17th, 2020 - Cardiac involvement as a complication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in children is a relatively new entity. We present our initial experience managing children with COVID-19-related acute myocardial inju...

Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopath...
https://doi.org/10.1002/ehf2.12854
ESC Heart Failure References; Mizia-Stec K, Caforio ALP et. al.

Sep 17th, 2020 - Cardiomyopathies are a heterogeneous group of disorders that increase the risk for atrial fibrillation (AF). The aim of the study is to assess the prevalence of AF, anticoagulation management, and risk of stroke/transient ischaemic attack (TIA) in...

HEllenic Registry on Myocarditis SyndromES on behalf of Hellenic Heart Failure Associat...
https://doi.org/10.1002/ehf2.12894
ESC Heart Failure References; Adamopoulos S, Miliopoulos D et. al.

Sep 16th, 2020 - Despite the existence of many studies, there are still limited data about the characteristics of myocarditis in Greece. This led to the creation of the Greek Myocarditis Registry aiming to document the different symptoms and treatment of myocardit...

First report of toxin-induced graft injury following liver transplantation for Yellow P...
https://doi.org/10.1002/hep.31553
Hepatology (Baltimore, Md.); Jasper S, Hakeem AR et. al.

Sep 16th, 2020 - Poisoning due to ingestion of yellow phosphorus (YP) containing rodenticide accounts for 17% of all poisoning in India and 0.3% in the USA.(1,2) YP disrupts oxidative phosphorylation and protein synthesis causing acute liver failure (ALF), renal i...

Fulminant myocarditis as an early presentation of SARS-CoV-2.
https://doi.org/10.1136/bcr-2020-237553
BMJ Case Reports; Naneishvili T, Khalil A et. al.

Sep 15th, 2020 - Myocarditis is well known to be caused by viral infections such as Coxsackie virus group B, human herpes virus 6 and parvovirus B19. However, during the current emerging outbreak of SARS-CoV-2, there have been few case reports describing myocardit...

see more →

Guidelines  13 results

Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy
https://www.nejm.org/doi/full/10.1056/NEJMc1903064
The New England Journal of Medicine;

Jun 12th, 2019 - Myocarditis after the use of immune checkpoint inhibitors is a potentially fatal complication. Immune suppression with glucocorticoids is often effective once the problem is identified. In a patient with glucocorticoid-refractory disease, use of a...

Recommendations for participation in competitive and leisure time sport in athletes wit...
https://doi.org/10.1093/eurheartj/ehy730
European Heart Journal; Pelliccia A, Solberg EE et. al.

Dec 18th, 2018 - Myocardial diseases are associated with an increased risk of potentially fatal cardiac arrhythmias and sudden cardiac death/cardiac arrest during exercise, including hypertrophic cardiomyopathy, dilated cardiomyopathy, left ventricular non-compact...

Cardiovascular pre-participation screening in young athletes: Recommendations of the As...
https://doi.org/10.1017/S1047951117001305
Cardiology in the Young; Fritsch P, Ehringer-Schetitska D et. al.

Aug 9th, 2017 - Sudden death in young competitive athletes can be avoided by implementation of pre-participation screening programmes. A screening programme should be performed only by trained physicians and should include the athlete's personal and family histor...

Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in...
https://doi.org/10.1097/PCC.0000000000000624
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies; Rossano JW, Cabrera AG et. al.

Mar 5th, 2016 - Heart failure is a serious complication that can occur in patients with a variety of congenital and acquired disorders including congenital heart disease, cardiomyopathy, and myocarditis. Furthermore, heart failure patients comprise an increasing ...

Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in...
https://doi.org/10.1097/PCC.0000000000000626
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies; Singh RK, Humlicek T et. al.

Mar 5th, 2016 - In this Consensus Statement, we review the etiology and pathophysiology of inflammatory processes seen in critically ill children with cardiac disease. Immunomodulatory therapies aimed at improving outcomes in patients with myocarditis, heart fail...

see more →

Clinicaltrials.gov  5,105 results

Myocarditis in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Co...
https://doi.org/10.1097/CRD.0000000000000341
Cardiology in Review; Jain S, Nolan SM et. al.

Sep 17th, 2020 - Cardiac involvement as a complication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in children is a relatively new entity. We present our initial experience managing children with COVID-19-related acute myocardial inju...

Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopath...
https://doi.org/10.1002/ehf2.12854
ESC Heart Failure References; Mizia-Stec K, Caforio ALP et. al.

Sep 17th, 2020 - Cardiomyopathies are a heterogeneous group of disorders that increase the risk for atrial fibrillation (AF). The aim of the study is to assess the prevalence of AF, anticoagulation management, and risk of stroke/transient ischaemic attack (TIA) in...

HEllenic Registry on Myocarditis SyndromES on behalf of Hellenic Heart Failure Associat...
https://doi.org/10.1002/ehf2.12894
ESC Heart Failure References; Adamopoulos S, Miliopoulos D et. al.

Sep 16th, 2020 - Despite the existence of many studies, there are still limited data about the characteristics of myocarditis in Greece. This led to the creation of the Greek Myocarditis Registry aiming to document the different symptoms and treatment of myocardit...

First report of toxin-induced graft injury following liver transplantation for Yellow P...
https://doi.org/10.1002/hep.31553
Hepatology (Baltimore, Md.); Jasper S, Hakeem AR et. al.

Sep 16th, 2020 - Poisoning due to ingestion of yellow phosphorus (YP) containing rodenticide accounts for 17% of all poisoning in India and 0.3% in the USA.(1,2) YP disrupts oxidative phosphorylation and protein synthesis causing acute liver failure (ALF), renal i...

Fulminant myocarditis as an early presentation of SARS-CoV-2.
https://doi.org/10.1136/bcr-2020-237553
BMJ Case Reports; Naneishvili T, Khalil A et. al.

Sep 15th, 2020 - Myocarditis is well known to be caused by viral infections such as Coxsackie virus group B, human herpes virus 6 and parvovirus B19. However, during the current emerging outbreak of SARS-CoV-2, there have been few case reports describing myocardit...

see more →

News  45 results

A young man with acute chest pain
https://www.mdedge.com/ccjm/article/206854/cardiology/young-man-acute-chest-pain/page/0/2?channel=230

Sep 3rd, 2019 - CASE CONTINUED Figure 2. Cardiac magnetic resonance imaging shows areas of patchy subepicardial late gadolinium enhancement (arrows).

Checkpoint Inhibitors: Who Gets Myocarditis?
https://www.medpagetoday.com/hematologyoncology/othercancers/81746

Aug 22nd, 2019 - The usual risk factors for myocarditis may not apply to who gets it while on immune checkpoint inhibiting cancer drugs, an FDA adverse event database suggested. Myocarditis associated with immune checkpoint inhibitors (ICIs) was nearly twice as li...

‘Encouraging’ responses seen with durvalumab plus R-CHOP in DLBCL
https://www.mdedge.com/hematology-oncology/article/203059/b-cell-lymphoma/encouraging-responses-seen-durvalumab-plus-r-chop/page/0/1?channel=59374

Jun 17th, 2019 - Safety “The safety profile was as expected for the components of the combination, and no new safety signals were observed,” Dr. Kline said.

Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy
https://www.nejm.org/doi/full/10.1056/NEJMc1903064
The New England Journal of Medicine;

Jun 12th, 2019 - Myocarditis after the use of immune checkpoint inhibitors is a potentially fatal complication. Immune suppression with glucocorticoids is often effective once the problem is identified. In a patient with glucocorticoid-refractory disease, use of a...

Case Study: Influenza Turned Lethal
https://www.medpagetoday.com/cardiology/prevention/75839

Oct 22nd, 2018 - While generally associated with mild infections, seasonal influenza can have serious complications beyond its well-known respiratory manifestations, which claim up to 650,000 lives annually world-wide. Accumulating data suggest that cardiovascular...

see more →

Patient Education  15 results see all →